Prevention of medication related osteonecrosis of the jaw after dentoalveolar surgery: An institution's experience

• Published in: Journal of clinical and experimental dentistry Vol. 12; no. 8; pp. e771 - e776
• Main Authors: Şahin, Onur, Tatar, Birkan, Ekmekcioğlu, Ceren, Aliyev, Toghrul, Odabaşı, Onur
• Format: Journal Article
• Language: English
• Published: Spain Medicina Oral S.L 01.08.2020
• ISSN: 1989-5488; 1989-5488
• DOI: 10.4317/jced.56837

Dentoalveolar surgery is a predisposing factor for medication related osteonecrosis of the jaw (MRONJ). The aim of our study was to evaluate the described surgical procedures to prevent the development of MRONJ after dentoalveolar surgery in patients receiving bisphosphonates. In this retrospective study, sixty-three dentoalveolar surgeries were performed on 44 patients taking bisphosphonate in accordance with the treatment procedures we described. The following procedures were applied to patients 1) use of antibiotics 2) performed dentoalveolar surgical procedures 3) fill the socket with leukocyte- and platelet-rich fibrin (L-PRF) 4) post-operative application of low level laser therapy through Nd: YAG laser 5) sutures were removed on post-op 14th day 6) long-term results were evaluated. Healing of all patients was uneventful. Complete mucosal healing was achieved in all patients at 1 month. There is no failure was observed in long-term follow-up. Because of the pathophysiology of MRONJ is not fully understood and has many risk factors, definitive protocols on prevention and treatment have not been established yet. Personal risk assessment is required for the prevention and treatment of MRONJ. The described surgical protocol may be considered to reduce the risk of developing MRONJ after dentoalveolar surgery due to its high success rate. Tooth extraction, medication related osteonecrosis of the jaw, preventive dentistry, L-PRF, low level laser therapy.